Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Treasury Shares: 2016-2024

Historic Treasury Shares for Rocket Pharmaceuticals (RCKT) over the last 3 years, with Dec 2022 value amounting to $47,000.

  • Rocket Pharmaceuticals' Treasury Shares was N/A to $47,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $47,000, marking a year-over-year change of. This contributed to the annual value of $47,000 for FY2022, which is N/A change from last year.
  • As of FY2022, Rocket Pharmaceuticals' Treasury Shares stood at $47,000, which was down 11.32% from $53,000 recorded in FY2019.
  • In the past 5 years, Rocket Pharmaceuticals' Treasury Shares registered a high of $5.7 million during FY2023, and its lowest value of $610,437 during FY2020.
  • Moreover, its 3-year median value for Treasury Shares was $2.7 million (2022), whereas its average is $3.3 million.
  • Data for Rocket Pharmaceuticals' Treasury Shares shows a maximum YoY tumbled of 92.07% (in 2019) over the last 5 years.
  • Rocket Pharmaceuticals' Treasury Shares (Yearly) stood at $668,000 in 2018, then tumbled by 92.07% to $53,000 in 2019, then reached $47,000 in 2022.